Compare GKOS & LMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GKOS | LMND |
|---|---|---|
| Founded | 1998 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 6.0B |
| IPO Year | 2015 | 2020 |
| Metric | GKOS | LMND |
|---|---|---|
| Price | $119.43 | $89.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 9 |
| Target Price | ★ $132.00 | $60.22 |
| AVG Volume (30 Days) | 847.6K | ★ 2.2M |
| Earning Date | 02-17-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $469,820,000.00 | ★ $658,300,000.00 |
| Revenue This Year | $32.39 | $40.24 |
| Revenue Next Year | $23.05 | $59.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 30.38 | ★ 33.66 |
| 52 Week Low | $73.16 | $24.31 |
| 52 Week High | $161.78 | $99.90 |
| Indicator | GKOS | LMND |
|---|---|---|
| Relative Strength Index (RSI) | 54.11 | 58.11 |
| Support Level | $116.73 | $85.75 |
| Resistance Level | $128.84 | $99.90 |
| Average True Range (ATR) | 6.18 | 6.28 |
| MACD | 0.07 | 0.68 |
| Stochastic Oscillator | 70.18 | 57.89 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.